Health Law Alliance (HLA) is proud to share that our very own Diana Yastrovskaya was recently featured for her expertise in a live discussion on Pharmacy Benefit Managers (PBMs) for Pennsylvania TV station, WJAC. In this segment, Diana offered her insights into the complex and often misunderstood role that PBMs play in the healthcare system.
The discussion centered on the impact of PBMs on local pharmacies, the breadth of PBM power, and the challenges this creates for independent businesses. Diana explained how PBMs act as intermediaries between insurers, pharmacies, and drug manufacturers, and how their practices can have significant implications for both patients and providers. She emphasized the importance of transparency in PBM operations and stressed that greater clarity could lead to more affordable and accessible medications for consumers.
Importantly, Diana shared how she works directly with independent pharmacies to help them push back against unfair PBM practices. Through her expertise in healthcare law and regulatory frameworks, she advocates for policies that empower smaller pharmacies to compete on a more level playing field.
Her participation in the WJAC discussion reflects HLA’s ongoing commitment to advancing critical conversations around healthcare law, policy, and practice. By breaking down complex industry dynamics and providing actionable guidance, Diana continues to champion fairness, efficiency, and patient well-being.
Read more about our best PBM Attorney, Diana Yastrovskaya, Esq.
MORE ARTICLES BY CATEGORY
When a Wound Care Audit Hits, Call Counsel First: How Specialized Attorneys Protect Your Practice
Medicare is intensifying scrutiny of wound care, OIG’s work plan spotlights skin-substitutes and related services, while CMS’s CERT program still finds sizable fee-for-service improper payments - so a targeted audit can escalate quickly to payment suspensions and referrals if mishandled.
Read More >>When Inventory Discrepancies Become Audit Nightmares: Understanding One of the Most Common and Costly Audit Findings
Inventory reconciliation is one of the most scrutinized areas in PBM and payer audits and even small discrepancies can trigger major financial, reputational, and regulatory fallout.
Read More >>Collateral Consequences of PBM Audits: What Pharmacies Need to Know
PBM audits can quickly escalate from routine reviews into high-stakes enforcement actions with lasting financial, reputational, and regulatory consequences for pharmacies.
Read More >>Victory for an Independent Pharmacy: Health Law Alliance Successfully Reverses Over $30,000 in PBM Inventory Discrepancy Findings
Health Law Alliance successfully overturned more than $30,000 in alleged inventory discrepancy findings asserted by Express Scripts’ Special Investigations Unit (SIU) against a Texas pharmacy.
Read More >>
